Literature DB >> 15528443

Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization.

Andrew R Tapper1, Sheri L McKinney, Raad Nashmi, Johannes Schwarz, Purnima Deshpande, Cesar Labarca, Paul Whiteaker, Michael J Marks, Allan C Collins, Henry A Lester.   

Abstract

The identity of nicotinic receptor subtypes sufficient to elicit both the acute and chronic effects of nicotine dependence is unknown. We engineered mutant mice with a4 nicotinic subunits containing a single point mutation, Leu9' --> Ala9' in the pore-forming M2 domain, rendering a4* receptors hypersensitive to nicotine. Selective activation of a4* nicotinic acetylcholine receptors with low doses of agonist recapitulates nicotine effects thought to be important in dependence, including reinforcement in response to acute nicotine administration, as well as tolerance and sensitization elicited by chronic nicotine administration. These data indicate that activation of a4* receptors is sufficient for nicotine-induced reward, tolerance, and sensitization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528443     DOI: 10.1126/science.1099420

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  309 in total

1.  AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.

Authors:  Lawrence Toll; Nurulain T Zaveri; Willma E Polgar; Faming Jiang; Taline V Khroyan; Wei Zhou; Xinmin Simon Xie; Gregory B Stauber; Matthew R Costello; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

2.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

Review 3.  Genetics of smoking and depression.

Authors:  Ming T Tsuang; Tracee Francis; Kyle Minor; Alison Thomas; William S Stone
Journal:  Hum Genet       Date:  2012-04-17       Impact factor: 4.132

4.  Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice.

Authors:  K J Jackson; M J Marks; R E Vann; X Chen; T F Gamage; J A Warner; M I Damaj
Journal:  J Pharmacol Exp Ther       Date:  2010-04-16       Impact factor: 4.030

5.  Novel α3β4 nicotinic acetylcholine receptor-selective ligands. Discovery, structure-activity studies, and pharmacological evaluation.

Authors:  Nurulain Zaveri; Faming Jiang; Cris Olsen; Willma Polgar; Lawrence Toll
Journal:  J Med Chem       Date:  2010-10-27       Impact factor: 7.446

6.  Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.

Authors:  Giulia Scuppa; Andrea Cippitelli; Lawrence Toll; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Drug Alcohol Depend       Date:  2015-09-08       Impact factor: 4.492

Review 7.  New insights into the genetics of addiction.

Authors:  Ming D Li; Margit Burmeister
Journal:  Nat Rev Genet       Date:  2009-04       Impact factor: 53.242

Review 8.  Constitutional mechanisms of vulnerability and resilience to nicotine dependence.

Authors:  N Hiroi; D Scott
Journal:  Mol Psychiatry       Date:  2009-02-24       Impact factor: 15.992

Review 9.  Smoking cessation: significance and implications for children.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

10.  Localized low-level re-expression of high-affinity mesolimbic nicotinic acetylcholine receptors restores nicotine-induced locomotion but not place conditioning.

Authors:  Y S Mineur; D H Brunzell; S R Grady; J M Lindstrom; J M McIntosh; M J Marks; S L King; M R Picciotto
Journal:  Genes Brain Behav       Date:  2008-12-11       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.